NZX Updates
NZX withdraws offer to buy stake in NSX
NZX announced today that it would withdraw its offer to buy a 50.1% stake in NSX of Australia, based on current indications that the purchase would be unlikely to receive the support of a sufficient number of NSX shareholders.
Mark Weldon's speech to SOE Directors
State Owned Enterprise Boards should set the direction of travel and drive high-performance cultures in SOEs that use their considerable assets to match - or exceed - private sector performance.
NZX and M-co agreement unconditional
NZX is pleased to advise that all conditions to the Sale and Purchase agreement for the acquisition of the energy and related assets of The Marketplace Company Limited (M-co) have been met today.
NZX to begin consultation on whole milk powder futures product
NZX plans to launch a cash settled futures contract that will enable dairy participants worldwide to hedge price risk in the whole milk powder market.
South African Competition Tribunal approves BESA and JSE merger
The Competition Tribunal in South Africa has given unconditional approval for the merger of Johannesburg Stock Exchange (JSE) and the Bond Exchange of South Africa Limited (BESA). An announcement was made to their market overnight New Zealand time. This decision, together with the approvals already obtained from the South African Reserve Bank and the Financial Services Board, means that all regulatory approvals required for the merger to go ahead have been obtained.
There are no conditions attached to the transaction.
Trading and capital raising up again in May
NZX Operating Metrics released today show strong trading in the month of May, with average daily trade numbers up 12% on the same period last year at 2,719, the highest since October last year. This is the first time that average daily number of trades has exceeded the previous year’s total since that date.
NZX confirms the sale of TZ1 Registry to Markit
NZX has completed the sale of the assets of the TZ1 Registry business to global financial services company Markit overnight. The deal value to NZX is US$37.1 million. At an overnight US$/NZ$ crossrate of 0.6544, this amounts to NZ$56.7 million. The initial consideration will be received up front in Markit shares, which will be held for the term of the deal through to the end of 2011. At that time the US$37.1 million figure is subject to change, with the potential to move either up or down by US$17 million, depending on the underlying performance of the TZ1 Registry business in that period.
Ryman Healthcare marks outstanding first decade on NZSX
Ryman Healthcare, provider of quality retirement living and care options for New Zealand’s elderly, marks 10 years as a listed company today.
